Germany's decision rule for setting ceiling prices of drugs: A comparative analysis with other decision rules

Applied Health Economics and Health Policy

Volumn 9, Issue 2, 2011, Pages 65-71

  Gandjour, Afschin ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Decision making; Pharmacoeconomics; Pricing

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISEASE SEVERITY; DRUG COST; DRUG USE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; QUALITY OF LIFE; REIMBURSEMENT;

ADVISORY COMMITTEES; BIOETHICAL ISSUES; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; GERMANY; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; PHARMACEUTICAL PREPARATIONS; QUALITY ASSURANCE, HEALTH CARE;

EID: 79951870208     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11586640-000000000-00000     Document Type: Article

References (20)

1. Drummond M, Sorenson C. Use of pharmacoeconomics in drug reimbursement in Australia, Canada and the UK: what can we learn from international experience? In: Arnold RJ, editor. Pharmacoeconomics: from theory to practice. New York: Taylor and Francis, 2009
2. Institute for Quality and Efficiency in Health Care. Methods for assessment of the relation of benefits to costs in the German Statutory Health Care System. Version 1.0 [in German]. Cologne: IQWiG, 2009 Oct 12
3. Raftery J. Regulation of drug pricing in Australia, England, and New Zealand. Clin AdvHematol Oncol 2009; 7 (1): 26-8
4. National Institute for Health and Clinical Excellence. Incorporating health economics in guidelines and assessing resource impact. London: NICE, 2007 Apr [online]. Available from URL: http://www.nice.org.uk/nicemedia/pdf/ guidelinesmanualchapter8.pdf [Accessed 2010 Sep 2]
5. Krauth C, John J, Aidelsburger P, et al. Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines 'Methods for assessment of the relation of benefits to costs in the German Statutory Health Care System' [in German]. Gesundheitswesen 2008 Jun; 70 (6): e1-16
6. Institute for Quality and Efficiency in Health Care. Documentation of comments on 'Draft method for evaluating the relation between cost and benefit in the German Statutory Health Insurance System, version 2.0' [in German]. Cologne: IQWiG, 2009 Oct 12
7. Institute for Quality and Efficiency in Health Care. Appraisal of IQWiG's Scientific Advisory Board's recommendations regarding draft version 1.1 [in German]. Cologne: IQWiG, 2009 Mar 16
8. Sozialgesetzbuch (SGB) Fünftes Buch (V) ' Gesetzliche Krankenversicherung ' (SGB V). Artikel 1 G. v. 20.12.1988 BGBl. I S. 2477, 2482; zuletzt geändert urch Artikel 2 G. v. 22.12.2010 BGBl. I S. 2309; Geltung ab 01.01.1989
9. Schwappach DL. Does it matter who you are or what you gain (Pubitemid 36442815)
10. Matschinger H, Angermeyer MC. The public's preferences concerning the allocation of financial resources to health care: results from a representative population survey in Germany. Eur Psychiatry 2004; 19 (8): 478-82 (Pubitemid 39602769)
11. Camidge R, Walker A, Oliver JJ, et al. Prognosis without treatment as a modifier in health economic assessments. BMJ 2005; 330 (7504): 1382-4 (Pubitemid 40839574)
12. Weinstein MC, Zeckhauser R. Critical ratios and efficient allocation. J Public Econ 1973; 2: 147-57
13. Bala MV, Zarkin GA, Mauskopf JA. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses. Value Health 2002; 5 (4): 338-46 (Pubitemid 36998746)
14. Birch S, Gafni A. Cost effectiveness/utility analyses: do current decision rules lead us to where we want to be? J Health Econ 1992; 11 (3): 279-96
15. Sendi P, Al MJ. Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty. Soc Sci Med 2003; 57 (6): 969-74 (Pubitemid 36876065)
16. Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med 2006; 62 (9): 2091-100
17. Dolan P, Shaw R, Tsuchiya A, et al. QALY maximisation and people's preferences: a methodological review of the literature. Health Econ 2005; 14 (2): 197-208 (Pubitemid 40253634)
18. Dworkin R. What is equality? Part 2: equality of resources. Philos Public Aff 1981; 10: 283-345
19. Dranove D, Kessler D, McClellan M, et al. Is more information better? The effects of 'report cards' on health care providers. J Polit Econ 2003; 111: 555-88 (Pubitemid 36967717)
20. Barro JR, Huckman RS, Kessler DP. The effects of cardiac specialty hospitals on the cost and quality of medical care. J Health Econ 2006; 25 (4): 702-21 (Pubitemid 43994188)